EMEA REVIEW
January 1st, 2004
BY KEITH NUTHALL
THE EUROPEAN Medicines Evaluation Agency (EMEA) has launched an action plan to improve its operational efficiency regarding human medicine controls. Part of an ongoing quality management initiative and a response to a 2003 audit, the 18 month plan aims at reinforcing EMEA's scientific evaluation, the transparency of its procedures and the scientific capacity of its staff, plus making its CPMP scientific committee more efficient.
THE EUROPEAN Medicines Evaluation Agency (EMEA) has launched an action plan to improve its operational efficiency regarding human medicine controls. Part of an ongoing quality management initiative and a response to a 2003 audit, the 18 month plan aims at reinforcing EMEA's scientific evaluation, the transparency of its procedures and the scientific capacity of its staff, plus making its CPMP scientific committee more efficient.
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.